Foundations of Drug Development and Pharmacoepidemiology

How do we ensure the medicines we take are both safe and effective? Understanding the journey of a drug from the laboratory to the public requires a solid grasp of both drug development processes and population-level safety monitoring. This course guides you through the foundational concepts of pharmaceutical development and pharmacoepidemiology. You will learn how clinical trials are designed, how drug safety is monitored after approval, and how researchers analyze real-world data to evaluate drug effectiveness in diverse populations. What you'll learn: - Understand the core stages of the drug development lifecycle, from preclinical research to regulatory approval. - Apply key epidemiological study designs, such as cohort and case-control studies, to assess drug safety and effectiveness. - Analyze post-marketing surveillance methods and pharmacovigilance strategies used to detect adverse drug reactions. - Evaluate real-world evidence (RWE) and real-world data (RWD) sources to understand how drugs perform in everyday clinical practice. - Interpret statistical measures of risk, association, and bias in pharmacoepidemiologic studies. You will begin by exploring fundamental terminology and the regulatory landscape of drug approval before moving into practical study designs and modern surveillance techniques. Through comprehensive written explanations and analytical exercises, you will build a strong conceptual framework for evaluating pharmaceutical safety. This course is designed for beginners, healthcare professionals, public health students, and anyone interested in pharmaceutical sciences, with no prior epidemiology experience required. Start your journey into the vital field of drug safety and public health today.